Reata Pharmaceuticals, Inc.

Symbool: RETA

NASDAQ

172.36

USD

Marktprijs vandaag

  • -89.3629

    Koers/Winst Verhouding

  • 0.0000

    Koers/Winst Groei Verhouding

  • 6.57B

    MRK Kapitalisatie

  • 0.00%

    DIV Rendement

Reata Pharmaceuticals, Inc. Structuur van het management

Informatie over het management

NaamTitel
Mr. Bhaskar AnandSenior Vice President & Chief Accounting Officer
Mr. Bhaskar AnandVice President & Chief Accounting Officer
Mr. Michael D. WortleyExecutive Vice President and Chief Legal & Compliance Officer
Dr. Samina Khan M.D.Chief Medical Officer & Senior Vice President
Mr. Michael D. WortleyExecutive Vice President & Chief Legal Officer
Dr. Colin J. Meyer M.D.Executive Vice President & Chief Innovation Officer
Mr. Steve HarmanSenior Vice President & Chief HR Officer
Mr. Dakota GallivanVice President & Chief Healthcare Compliance Officer
Ms. Dawn Carter BirExecutive Vice President & Chief Commercial Officer
Dr. W. Christian Wigley Ph.D.Senior Vice President & Chief Scientific Officer
Mr. J. Warren HuffChairman & Chief Executive Officer
Ms. Elaine CastellanosConsultant
Mr. J. Warren HuffChairman, Chief Executive Officer & Sec.
Mr. Michael D. WortleyExecutive Vice President and Chief Legal & Compliance Officer
Mr. J. Warren HuffChairman, Chief Executive Officer & Sec.
Mr. Manmeet Singh SoniChief Operating Officer, Chief Financial Officer & Pres